Cargando…
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
Immune thrombocytopenia (ITP) is an acquired hemorrhagic condition characterized by the accelerated clearance of platelets caused by antiplatelet autoantibodies. A platelet count in peripheral blood <100 × 10(9)/L is the most important criterion for the diagnosis of ITP. However, the platelet cou...
Autor principal: | Nomura, Shosaku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948655/ https://www.ncbi.nlm.nih.gov/pubmed/27441004 http://dx.doi.org/10.4137/CMBD.S39643 |
Ejemplares similares
-
Effect of Cytokine Gene Polymorphisms on Eltrombopag Reactivity in Japanese Patients with Immune Thrombocytopenia
por: Nomura, Shosaku, et al.
Publicado: (2021) -
Recent advances in the mechanisms and treatment of immune thrombocytopenia
por: Provan, Drew, et al.
Publicado: (2022) -
Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments
por: Audia, Sylvain, et al.
Publicado: (2021) -
Recent advances in treatments of adult immune thrombocytopenia
por: Kim, Dae Sik
Publicado: (2022) -
Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia
por: Vayne, Caroline, et al.
Publicado: (2020)